Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke prevention

被引：7
|
作者：
Hohnloser, Stefan H.
Lopes, Renato D.
机构：
[1] Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany
[2] Duke Med, Duke Clin Res Inst, Durham, NC USA
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷 / 47期
关键词：
WARFARIN; DABIGATRAN; APIXABAN;
D O I：
10.1093/eurheartj/ehu386
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This editorial refers to 'Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial'(+), by G. Breithardt et al. on page 3377.
引用
收藏
页码：3323 / 3325
页数：3
相关论文
共 50 条
  • [1] Stroke Prevention in Nonvalvular Atrial Fibrillation: Update on Target-Specific Oral Anticoagulants
    Patrick, Carol
    Clarke, Randi
    [J]. JOURNAL OF CONTINUING EDUCATION IN NURSING, 2015, 46 (04): : 152 - 154
  • [2] Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
    Russo, Vincenzo
    Rago, Anna
    Proietti, Riccardo
    Di Meo, Federica
    Papa, Andrea Antonio
    Calabro, Paolo
    D'Onofrio, Antonio
    Nigro, Gerardo
    AlTurki, Ahmed
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2017, 8 (02) : 67 - 75
  • [3] An Updated Review of Target-Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
    Cove, Christina L.
    Hylek, Elaine M.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (05):
  • [4] Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
    Ahmad, Saad
    Wilt, Heath
    [J]. OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2016, 10 : 110 - 116
  • [5] Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Aronow, Wilbert S.
    Panza, Julio A.
    Cooper, Howard A.
    [J]. HEART, 2019, 105 (18) : 1432 - 1436
  • [6] Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Senoo, Keitaro
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2014, 39 (09) : 319 - 344
  • [7] CLINICAL EVIDENCE IN THE USE OF DIRECT ACTING ORAL ANTICOAGULANTS FOR ATRIAL FIBRILLATION WITH VALVULAR HEART DISEASE
    Engle, Amanda L.
    Rudd, Kelly M.
    Winans, Amanda R. M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E384 - E384
  • [8] Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation
    Destephan, C.
    Waller, A. H.
    Patel, R. J.
    Dhruvakumar, S.
    Mazza, V.
    Gerula, C.
    Maher, J.
    Kaluski, E.
    [J]. MINERVA CARDIOANGIOLOGICA, 2012, 60 (04): : 425 - 431
  • [9] New oral anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation
    Bosch, Montserrat
    Llop, Roser
    Lalueza, Pilar
    del Mar Villar, Maria
    [J]. MEDICINA CLINICA, 2013, 140 (05): : 229 - 231
  • [10] Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
    Di Biase, Luigi
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
12345